MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2018 International Congress

    Disease progression and survival of multiple system atrophy: A prospective French cohort study

    A. Foubert-Samier, A. Pavy-Letraon, F. Guillet, C. Helmer, M. LeGoff, F. Tison, F. Rascol, C. Proust-Lima, W. Meissner (Bordeaux, France)

    Objective: We report the first prospective natural history study of MSA combining progression of the disease and mortality. Background: Multiple system atrophy (MSA) is a…
  • 2018 International Congress

    Probable MSA presenting initially with urinary retention

    S. Simeoni, R. Sakakibara, J. Panicker (London, United Kingdom)

    Objective: We describe 6 cases of probable MSA presenting with urinary retention/incomplete bladder emptying. Background: MSA is a progressive neurodegenerative adult-onset disease whose clinical features…
  • 2018 International Congress

    Prevalence of REM sleep behavior disorder and sleep-disordered breathing in multiple system atrophy: A meta-analysis

    SL. Wu, CS. Chuang (Changhua, Taiwan)

    Objective: This study aimed to evaluate the prevalence of rapid eye movement sleep behavior disorder (RBD), stridor, sleep-disordered breathing and periodic limb movements in sleep…
  • 2018 International Congress

    A Young Man with Multiple System Atrophy: A Case Report

    DR. Carneiro, M. Sousa, C. Januário, A. Morgadinho (Coimbra, Portugal)

    Objective: To describe the case of a young man with the diagnosis of probable Multiple System Atrophy. Background: MSA is a complex neurodegenerative disorder. The…
  • 2018 International Congress

    Caregiver Burden in a Multidisciplinary MSA Clinic

    M. Salinas, E. Kent, S. Vernino, P. Khemani (Dallas, TX, USA)

    Objective: To explore the correlation between disease and caregiver burden in MSA. Background: For patients with Multiple System Atrophy (MSA), the increasing loss of independence…
  • 2017 International Congress

    Differentiating Parkinsonism with Spatio-temporal dynamics (real-time MRI) and Acoustics of Speech (spectrogram)

    S. GUDWANI, S.S. Kumaran, M. Behari (New Delhi, India)

    Objective: Differentially diagnosing subgroups in Parkinsonism for optimal rehabilitation thus designed study with real-time dynamic magnetic resonance imaging (MRI) and automated acoustic analysis Background: In Parkinsonism with…
  • 2017 International Congress

    Semiquantitative analyses of DAT-SPECT imaging with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism

    N. Morimoto, M. Takamiya, M. Morimoto (Takamatsu, Japan)

    Objective: We investigate the usefulness Dopamine transporter (DAT)-SPECT with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism. Background: DAT-SPECT imaging is sensitive…
  • 2017 International Congress

    Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study

    E. Fiorenzato, L. Weis, A. Antonini, R. Biundo (Venice-Lido, Italy)

    Objective: To characterize the progression of cognitive decline and compare the neuropsychological 15-month profile across PSP, MSA and PD. Background: Cognitive impairments are frequently reported in…
  • 2017 International Congress

    Predictors of cognitive impairment in multiple system atrophy

    M. Hatakeyama, T. Sato, T. Takahashi, M. Kanazawa, O. Onodera, M. Nishizawa (Niigata, Japan)

    Objective: To determine predictors of cognitive impairment in patients with multiple system atrophy (MSA). Background: Although dementia is not a diagnostic criteria for MSA, an…
  • 2017 International Congress

    Clinical Phenotype in Patients with Multiple System Atrophy in the Mexican Population

    S. Isais-Millán, C. Perez-Lohman, K. Salinas Barboza, A. Cervantes Arriaga, M. Rodriguez Violante, L. Mendoza Vega, N. Davila Avila, A. DelaCruz Landero (Mexico City, Mexico)

    Objective: To describe the clinical phenotype of patients with MSA in a center in Mexico City Background: Multiple System Atrophy (MSA) is an adult-onset;progressive,neurodegenerative disease…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley